Kanabo Group (LSE:KNB) FCF Margin % : -275.56% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Kanabo Group FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Kanabo Group's Free Cash Flow for the six months ended in Dec. 2023 was £-1.23 Mil. Kanabo Group's Revenue for the six months ended in Dec. 2023 was £0.45 Mil. Therefore, Kanabo Group's FCF Margin % for the quarter that ended in Dec. 2023 was -275.56%.

As of today, Kanabo Group's current FCF Yield % is -30.17%.

The historical rank and industry rank for Kanabo Group's FCF Margin % or its related term are showing as below:

LSE:KNB' s FCF Margin % Range Over the Past 10 Years
Min: -2894.52 Med: -771.04 Max: -341.12
Current: -341.12

During the past 7 years, the highest FCF Margin % of Kanabo Group was -341.12%. The lowest was -2894.52%. And the median was -771.04%.

LSE:KNB's FCF Margin % is ranked worse than
95.8% of 667 companies
in the Healthcare Providers & Services industry
Industry Median: 1.42 vs LSE:KNB: -341.12

Kanabo Group FCF Margin % Historical Data

The historical data trend for Kanabo Group's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kanabo Group FCF Margin % Chart

Kanabo Group Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-890.00

-2,894.52

-652.07

-341.12

Kanabo Group Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial								-1,868.97	-926.36	-471.98	-406.24	-275.56

Competitive Comparison of Kanabo Group's FCF Margin %

For the Medical Care Facilities subindustry, Kanabo Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kanabo Group's FCF Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Kanabo Group's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Kanabo Group's FCF Margin % falls into.

Kanabo Group FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Kanabo Group's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-3.053	/	0.895
	=	-341.12 %

Kanabo Group's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-1.229	/	0.446
	=	-275.56 %

Kanabo Group FCF Margin % Related Terms

Thank you for viewing the detailed overview of Kanabo Group's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kanabo Group (LSE:KNB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Kanabo Group PLC (LSE:KNB) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

3WD:Germany

Address

137-139 Brent Street, Churchill House, London, GBR, NW4 4DJ

Website

https://www.kanabogroup.com

Kanabo Group PLC is a research and development company engaged in selling a range of THC-Free retail CBD products in the markets and it is in the process of developing medical cannabis products. Its reportable segments include Primary Care and Secondary Care. The Primary Care segment includes Tele pharma services provided by GPS and The Secondary Care segment includes the development and distribution of cannabis-derived medical and wellness products. Geographically company has a presence in the United Kingdom, Israel, and others.

Kanabo Group (LSE:KNB) Headlines

No Headlines